Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 1:18 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2017–2040 of 8,697 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Longitudinal Studies Clear all

Conditions: Neurological Disorder, Autoimmune Diseases
Interventions: Mycophenolate Mofetil, Azathioprine; Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 17
States / cities: Palo Alto, California • Miami, Florida • Chicago, Illinois + 12 more

Conditions: Dyslipidemia
Interventions: Niacin extended-release (NER), Niacin extended-release (NER) placebo, Aspirin (ASA), Aspirin (ASA) placebo; Drug
Lead sponsor: Abbott; Industry
Eligibility: 18 Years and older
Enrollment: 276 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 40
States / cities: Birmingham, Alabama • Anaheim, California • Walnut Creek, California + 35 more

Conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Psychotic Disorders, Bipolar Disorder
Interventions: PGx testing guided treatment (PGT); Biological
Lead sponsor: Northwell Health; Other
Eligibility: 15 Years to 64 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Glen Oaks, New York

Conditions: Hernia, Incisional Hernia, Hernia, Inguinal, Indirect, Hernia, Inguinal, Direct, Inguinal Hernia
Interventions: Hernia repair; Procedure
Lead sponsor: Intuitive Surgical; Industry
Eligibility: 18 Years and older
Enrollment: 944 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 17
States / cities: Beverly Hills, California • Nashville, California • Oakland, California + 14 more

Conditions: Exercise Training
Interventions: Not listed
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 6 Years and older
Enrollment: 633 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Waltham, Massachusetts

Conditions: End-stage Liver Disease, Renal Insufficiency, Renal Failure
Interventions: mycophenolate mofetil, placebo medication; Drug · Other
Lead sponsor: Baylor College of Medicine; Other
Eligibility: Up to 16 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Malignant Distal Biliary Obstruction
Interventions: EUS-guided biliary drainage; Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 7
States / cities: Aurora, Colorado • Gainesville, Florida • Orlando, Florida + 4 more

Conditions: Pain, Aging
Interventions: RHA® Redensity with new anesthetic agent, RHA® Redensity with lidocaine; Device
Lead sponsor: Teoxane SA; Industry
Eligibility: 22 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 2
States / cities: Birmingham, Alabama • New York, New York

Conditions: Diabetes Mellitus
Interventions: Continuous Glucose Monitoring System; Device
Lead sponsor: Senseonics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 9
States / cities: Concord, California • Escondido, California • Walnut Creek, California + 5 more

Conditions: Back Pain
Interventions: HF10 Therapy, CMM; Device · Other
Lead sponsor: Nevro Corp; Industry
Eligibility: 18 Years and older
Enrollment: 211 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Redwood City, California

Conditions: Disorder of Nipple, Breast Neoplasms
Interventions: MRI; Device
Lead sponsor: Duke University; Other
Eligibility: 22 Years and older · Female only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Knee Osteoarthritis
Interventions: Biological: PTP-001; Biological
Lead sponsor: Bioventus LLC; Industry
Eligibility: 40 Years to 80 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 2
States / cities: Durham, North Carolina • North Charleston, South Carolina

Conditions: Ventral Hernia
Interventions: Open retromuscular ventral hernia repair, Laparoscopic retromuscular ventral hernia repair, Robotic-assisted retromuscular ventral hernia repair; Procedure · Device
Lead sponsor: Intuitive Surgical; Industry
Eligibility: 18 Years to 89 Years
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 4
States / cities: Oakland, California • Sacramento, California • Santa Clara, California + 1 more

Conditions: Flexor Tendon
Interventions: Standard of Care Surgical Procedure, VersaWrap Treatment; Procedure · Device
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 99 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Uveitis, Posterior, Vasculitis Retinal
Interventions: H.P. ACTHAR GEL; Drug
Lead sponsor: Ocular Immunology and Uveitis Foundation; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Waltham, Massachusetts

Conditions: Emergency Contraception
Interventions: CDB-2914, levonorgestrel; Drug
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older · Female only
Enrollment: 1,672 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1999 – 2001
U.S. locations: 6
States / cities: Los Angeles, California • Denver, Colorado • New York, New York + 3 more

Conditions: Coagulation Disorder
Interventions: TAK-330, SOC 4F-PCC; Drug
Lead sponsor: Takeda; Industry
Eligibility: 18 Years and older
Enrollment: 440 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 13
States / cities: Arkansas City, Arkansas • Sacramento, California • Englewood, Colorado + 10 more

Conditions: Migraine
Interventions: Not listed
Lead sponsor: AbbVie; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 1,884 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2036
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Contraception
Interventions: FemBloc; Device
Lead sponsor: Femasys Inc.; Industry
Eligibility: 21 Years to 45 Years · Female only
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2027
U.S. locations: 6
States / cities: Chandler, Arizona • Phoenix, Arizona • Columbus, Georgia + 3 more

Conditions: Wound, Ulcer, Burns
Interventions: Negative pressure wound therapy coupled with instillation, Standard Negative Pressure Wound Therapy; Device
Lead sponsor: Loma Linda University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Retinal Detachment, Epiretinal Membrane, Macular Hole, Fuchs Endothelial Dystrophy
Interventions: Not listed
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 750 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2017
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Dry Eye
Interventions: Not listed
Lead sponsor: Toyos Clinic; Other
Eligibility: 22 Years to 85 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Obstructed Defecation, Pelvic Organ Prolapse
Interventions: Laparoscopic abdominal ventral rectopexy, Transvaginal sacrospinous rectopexy; Procedure
Lead sponsor: Endeavor Health; Other
Eligibility: 18 Years to 80 Years · Female only
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 2
States / cities: Skokie, Illinois • New York, New York

Conditions: Ocular Hypertension
Interventions: Sensimed Triggersfish® (TF); Device
Lead sponsor: Sensimed AG; Industry
Eligibility: 18 Years to 100 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: New Haven, Connecticut

Search by objective public record fields.

Disease-Modifying Treatments for Myasthenia Gravis

Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Extended-release Plus Aspirin

Prospective Pharmacogenetic Testing and Clinical Outcomes in Patients With Early-Phase Psychosis

A Prospective Study to Compare the Clinical Outcomes, Pain and Patient Quality of Life for Hernia Patients

Analytic, Prospective Cohort Study of Athletes Enrolled in an Exercise Training Intervention

Trial of Calcineurin Inhibitor-Sparing Immunosuppression Regimen in Pediatric Liver Transplantation

EUS-Guided Biliary Drainage in Patients With Inoperable Malignant Distal Biliary Obstruction and Failed ERCP: a Prospective Feasibility Multicenter Trial

RHA® Redensity With New Anesthetic Agent Perioral Rhytids (PAS)

Evaluation of the Accuracy of an Implanted Glucose Sensor

Comparison of HF10 Therapy Combined With CMM to CMM Alone in the Treatment of Non-Surgical Refractory Back Pain

Diagnostic Utility of MRI in Female Patients With Nipple Discharge: A Prospective Trial

Safety Study of PTP-001 for Treating Knee Osteoarthritis

Pain and Quality of Life After Retromuscular Ventral Hernia Repair (RECOVER)

Prospective Randomized Blinded Trial of VersaWrap Tendon Protector for Zone 2 Flexor Tendon Injuries

Efficacy and Safety of H.P. ACTHAR GEL in Adults With Retinal Vasculitis

Efficacy Trial of CDB 2914 for Emergency Contraception

A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery

Observational Study to Assess Adverse Events When Adult Female Participants Are Treated With Ubrelvy (Ubrogepant) or Qulipta (Atogepant) During Pregnancy

FemBloc® Permanent Contraception - Confirmation Feasibility Trial

Coupling Negative Pressure Wound Therapy With Instillation

PIONEER: Intraoperative and Perioperative OCT Study

Single Center, Prospective, Randomized, Controlled, Non-significant Risk

Prospective Randomized Controlled Trial of Obstructed Defecation Surgery

IOP Patterns in Ocular Hypertensive Patients Newly Converted to Glaucoma vs Stable Ocular Hypertensive Patients